Mathias et al. (58) investigated the role of LINC01871 in 5 molecular subtypes of breast cancer and found that LINC01871 is associated with immune response activation and favorable OS in patients with basal-like breast cancers. The gene discussed is LINC01871; the disease is breast carcinoma.